Impact of atrial mitral and tricuspid regurgitation on atrial fibrillation recurrence after ablation.


Journal

Journal of electrocardiology
ISSN: 1532-8430
Titre abrégé: J Electrocardiol
Pays: United States
ID NLM: 0153605

Informations de publication

Date de publication:
Historique:
received: 30 11 2020
revised: 12 04 2021
accepted: 13 04 2021
pubmed: 28 4 2021
medline: 10 7 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Atrial fibrillation (AF) induces functional mitral regurgitation (FMR) and tricuspid regurgitation (FTR) during atrial remodeling. FMR and FTR are associated with AF prognosis, but the effects for AF recurrence after ablation have not been determined conclusively. Two hundred thirty nine patients who underwent AF ablation were enrolled. Forty five patients were excluded. In total, 194 patients were analyzed. FMR and FTR were assessed by echocardiography. The left atrial volume index (LAVI) was evaluated by contrast-enhanced computed tomography. Significant FMR and moderate FTR were observed in 15 (7.7%) and in 25 (12.9%) patients, respectively. The severity of tricuspid regurgitation (TR) significant correlated with age, NT-proBNP, and LAVI. During a 13.4 month follow-up period of, 39 patients (20.1%) demonstrated AF recurrence. In the Cox proportional-hazards model, E/e', FTR, and LAVI, were termed as predictor factors of AF recurrence (E/e'. hazard ratio [HR] = 1.117; P = 0.019, significant FTR. HR = 4.679; P = 0.041, LAVI. HR = 1.057; P = 0.003). Kaplan-Meier analysis showed that AF recurrence was more frequent in FTR compared with the nonsignificant FTR cases (log-rank, P = 0.001). Although survival analysis showed no difference with or without FMR, the presence of FMR and FTR was strongly associated with high-AF recurrence (log-rank, P = 0.004). AF recurrence was associated with E/e', LAVI, and extensive FTR. Specifically, the combination of FTR and FMR markedly worsens the AF prognosis.

Sections du résumé

BACKGROUND
Atrial fibrillation (AF) induces functional mitral regurgitation (FMR) and tricuspid regurgitation (FTR) during atrial remodeling. FMR and FTR are associated with AF prognosis, but the effects for AF recurrence after ablation have not been determined conclusively.
METHODS
Two hundred thirty nine patients who underwent AF ablation were enrolled. Forty five patients were excluded. In total, 194 patients were analyzed. FMR and FTR were assessed by echocardiography. The left atrial volume index (LAVI) was evaluated by contrast-enhanced computed tomography.
RESULTS
Significant FMR and moderate FTR were observed in 15 (7.7%) and in 25 (12.9%) patients, respectively. The severity of tricuspid regurgitation (TR) significant correlated with age, NT-proBNP, and LAVI. During a 13.4 month follow-up period of, 39 patients (20.1%) demonstrated AF recurrence. In the Cox proportional-hazards model, E/e', FTR, and LAVI, were termed as predictor factors of AF recurrence (E/e'. hazard ratio [HR] = 1.117; P = 0.019, significant FTR. HR = 4.679; P = 0.041, LAVI. HR = 1.057; P = 0.003). Kaplan-Meier analysis showed that AF recurrence was more frequent in FTR compared with the nonsignificant FTR cases (log-rank, P = 0.001). Although survival analysis showed no difference with or without FMR, the presence of FMR and FTR was strongly associated with high-AF recurrence (log-rank, P = 0.004).
CONCLUSIONS
AF recurrence was associated with E/e', LAVI, and extensive FTR. Specifically, the combination of FTR and FMR markedly worsens the AF prognosis.

Identifiants

pubmed: 33906059
pii: S0022-0736(21)00077-7
doi: 10.1016/j.jelectrocard.2021.04.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114-121

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Keijiro Nakamura (K)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan. Electronic address: nakamura1-04@live.jp.

Takahito Takagi (T)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Norihiro Kogame (N)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Masako Asami (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Yasutake Toyoda (Y)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Yoshinari Enomoto (Y)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Hidehiko Hara (H)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Masao Moroi (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Mahito Noro (M)

Division of Cardiovascular Medicine, Odawara Cardiovascular Hospital, Japan.

Kaoru Sugi (K)

Division of Cardiovascular Medicine, Odawara Cardiovascular Hospital, Japan.

Masato Nakamura (M)

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH